Concurrent Session 9: Pain: Clinical Aspects
Date/Time: Saturday, April 9, 2022 - 2:00 PM to 3:30 PM
Log in to Add to My Schedule
Description:
Comorbidities in OA: A Cause or Consequence?
Philippa Nicolson, BPhty, PhD - The University of Oxford
Individuals with OA have a high frequency of comorbidities. The presence of comorbidities has a significant impact on functional limitations, as well as clinical management, and long-term outcomes. Certain comorbidities appear to be more common among individuals with OA, but are these a cause, or a consequence of OA itself? This presentation will summarize research to date that explores the potential causal relationships between OA and comorbidities. Research to understand shared risks and processes underlying OA and common comorbidities will be discussed, and the importance of identifying and addressing comorbidities will be highlighted.
Abstract(s):
73
COMPARISON OF EXERCISE THERAPY, NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, AND OPIOIDS FOR KNEE OSTEOARTHRITIS PAIN: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
Carsten B. Juhl, PhD, University of Southern DenmarkV-74
SAFETY, TOLERABILITY AND PHARMACOKINETICS/PHARMACODYNAMIC EVALUATION OF PROPERTIES OF IN1011-N17 AFTER ORAL ADMINISTRATION IN HEALTHY VOLUNTEERS WITH EFFECT COMPARISON OF SOLUBILITY ENHANCED FORMULATION.
Yeseul Shin, iNTherapeuticsV-75
HAS THE COVID 19 PANDEMIC IMPACTED THE MANAGEMENT OF CHRONIC MUSCULOSKELETAL PAIN?
Chenchen Wang, MD, MS, Tufts Medical CenterV-76
THE MEDIATING EFFECT OF OSTEOPHYTES ON THE RELATIONSHIP BETWEEN CARTILAGE MORPHOLOGY AND CHANGES IN KNEE SYMPTOMS IN PATIENTS WITH KNEE OSTEOARTHRITIS
Tianxiang Fan, Master, Clinical Research Center, Zhujiang Hospital, Southern Medical UniversityV-77
PAIN SEVERITY ACROSS HAND OSTEOARTHRITIS PHENOTYPES BASED ON A BIOPSYCHOSOCIAL APPROACH
Elisabeth Mulrooney, PT, Diakonhjemmet HospitalV-78
USING ADVANCED STATISTICAL AND GRAPHICAL METHODS TO DEVELOP A MULTI-DOMAIN INDEX OF MOVEMENT-EVOKED PAIN
Staja Q. Booker, PhD, RN, University of Florida